locus_rank 	locus_pvalue	locus_pos_hg19	SZ 	protein_coding_genes	OMIM 	NHGRI_GWAS_catalog 	KO_phenotype 1	3.48E-31	chr6:28303247-28712247 	Y 	Locus too broad 		SCZ pmid=19571808/19571809/ 19571811 	2	3.36E-19	chr1:97792625-98559084 	Y 	DPYD MIR137 (micro-RNA) 	DPYD 5-fluorouracil toxicity; DPYD Dihydropyrimidine dehydrogenase deficiency 	ASD-ADHD-BIP-MDD-SCZ p=2E-11 pmid=23453885; SCZ p=2E-11 pmid=21926974 	3	6.20E-19	chr10:104423800-105165583 	Y 	ARL3 AS3MT C10orf32 CNNM2 CYP17A1 INA NT5C2 PCGF6 PDCD11 SFXN2 TAF5 TRIM8 USMG5 WBP1L 	"CNNM2 Hypomagnesemia 6, renal; CYP17A1 17,20-lyase deficiency, isolated; CYP17A1 17- alpha-hydroxylase/17,20-lyase deficiency "	ASD-ADHD-BIP-MDD-SCZ p=2E-9 pmid=23453885; Blood pressure p=4E-17 pmid=21572416; Coronary heart disease p=1E-9 pmid=21378990; Intracranial aneurysm p=1E-9 pmid=20364137; SCZ p=2E-9 pmid=22688191; Systolic blood pressure p=7E-26 pmid=21909115 	Arl3 nervous; Cyp17a1 behavioral neurological; Ina nervous 4	3.22E-18	chr12:2321860-2523731 	Y 	CACNA1C 	CACNA1C Brugada syndrome 3; CACNA1C Timothy syndrome 	SCZ: pmid=22614287; ASD-ADHD- BIP-MDD-SCZ p=5E-9 pmid=23453885; Bipolar disorder p=2E-8 pmid=21926972; Bipolar disorder and major depressive disorder (combined) p=3E-8 pmid=20351715; Red blood cell traits p=3E-9 pmid=23222517 	Cacna1c behavioral neurological nervous 5	1.74E-15	chr8:143309503-143330533 	Y 	TSNARE1 		SCZ pmid = 23974872 	6	7.98E-15	chr4:103146888-103198090 	N 	SLC39A8 		Blood pressure p=1E-10 pmid=21909110; Body mass index p=2E-13 pmid=20935630; Diastolic blood pressure p=2E-17 pmid=21909115; HDL cholesterol p=7E-11 pmid=20686565; Systolic blood pressure p=3E-14 pmid=21909115 	7	8.20E-15	chr7:1896096-2190096 	Y 	MAD1L1 	"MAD1L1 Lymphoma, somatic; MAD1L1 Prostate cancer, somatic "	SCZ p=2E-9 pmid=22688191 	8	1.10E-14	chr5:60499143-60843543 	Y 	ZSWIM6 		SCZ p=4E-8 pmid=22688191 	9	1.86E-14	chr12:123448113-123909113 	Y 	ABCB9 ARL6IP4 C12orf65 CDK2AP1 MPHOSPH9 OGFOD2 PITPNM2 RILPL2 SBNO1 SETD8 	"C12orf65 Combined oxidative phosphorylation deficiency 7; C12orf65 Spastic paraplegia 55, autosomal recessive "	SCZ pmid = 23974872; HDL cholesterol p=8E-9 pmid=20686565; Head circumference (infant) p=8E-9 pmid=22504419; Height p=4E-15 pmid=20881960 	10	5.65E-14	chr2:200715237-200848037 	Y 	AC073043.2 C2orf47 C2orf69 TYW5 		SCZ pmid = 23974872 	11	8.30E-14	chr15:91416560-91429040 	N 	FES FURIN MAN2A2 			Fes nervous; Furin nervous 12	1.05E-13	chr3:36843183-36945783 	N 	TRANK1 		Bipolar disorder p=1E-12 pmid=22182935 	13	1.36E-13	chr14:103996234-104184834 	N 	AL049840.1 APOPT1 BAG5 CKB KLC1 PPP1R13B TRMT61A XRCC3 ZFYVE21 	"XRCC3 Breast cancer, susceptibility to; XRCC3 Melanoma, cutaneous malignant, 6 "		Ckb behavioral neurological nervous; Klc1 behavioral neurological nervous 14	2.44E-13	chr15:78803032-78926732 	N 	AC027228.1 AGPHD1 CHRNA3 CHRNA5 CHRNB4 IREB2 PSMA4 	"CHRNA3 Lung cancer susceptibility 2; CHRNA5 Lung cancer susceptibility 2; CHRNA5 Nicotine dependence, susceptibility to "	Airflow obstruction p=3E-9 pmid=22837378; Chronic obstructive pulmonary disease p=1E-10 pmid=19300482; Lung adenocarcinoma p=2E-51 pmid=19836008; Lung cancer p=3E- 26 pmid=19654303; Nicotine dependence p=6E-20 pmid=18385739; Response to tocilizumab in rheumatoid arthritis p=4E-8 pmid=22491018; Smoking behavior p=3E-73 pmid=20418890 	Chrna3 behavioral neurological nervous; Chrna5 behavioral neurological nervous; Chrnb4 behavioral neurological nervous; Ireb2 behavioral neurological nervous 15	3.03E-13	chr7:110843815-111205915 	N 	IMMP2L 			16	1.09E-12	chr11:130714610-130749330 	Y 	SNX19 		SCZ pmid = 23974872 	17	1.53E-12	chr2:185601420-185785420 	Y 	ZNF804A 		SCZ pmid = 20368704 	18	1.61E-12	chrX:21193266-21570266 	N 	CNKSR2 			19	1.97E-12	chr10:18681005-18770105 	Y 	CACNB2 	CACNB2 Brugada syndrome 4 	SCZ pmid = 23974872; Blood pressure p=2E-16 pmid=21909110; Diastolic blood pressure p=1E-8 pmid=19430479 	Cacnb2 nervous 20	2.02E-12	chr12:57428314-57682971 	N 	LRP1 MYO1A NAB2 NDUFA4L2 NXPH4 R3HDM2 SHMT2 STAC3 STAT6 TAC3 TMEM194A 	"MYO1A Deafness, autosomal dominant 48; TAC3 Hypogonadotropic hypogonadism 10 with or without anosmia "	Abdominal aortic aneurysm p=5E-10 pmid=22055160; IgE levels p=2E-12 pmid=22075330; Migraine p=4E-9 pmid=21666692; Pulmonary function p=1E-8 pmid=21946350 	Nab2 behavioral neurological nervous 21	2.03E-12	chr1:73766426-73991366 	Y 	LRRIQ3 * 		SCZ pmid = 23974872 	22	2.32E-12	chr2:233559301-233753501 	Y 	C2orf82 EFHD1 GIGYF2 KCNJ13 NGEF 	GIGYF2 Parkinson disease 11; KCNJ13 Leber congenital amaurosis 16; KCNJ13 Snowflake vitreoretinal degeneration 	SCZ pmid = 23974872 	Gigyf2 behavioral neurological nervous; Ngef nervous 23	2.80E-12	chr11:124610007-124620147 	Y 	ESAM MSANTD2 NRGN VSIG2 		SCZ pmid=19571808 	Nrgn behavioral neurological nervous 24	3.34E-12	chr18:52747686-53200117 	Y 	TCF4 	"TCF4 Diabetes mellitus, type 2, susceptibility to; TCF4 Pitt-Hopkins syndrome "	ASD-ADHD-BIP-MDD-SCZ p=3E-10 pmid=23453885; SCZ p=3E-10 pmid=23571483 	Tcf4 nervous 25	1.26E-11	chr11:46342943-46751213 	Y 	AMBRA1 ARHGAP1 ATG13 CHRM4 CKAP5 CREB3L1 DGKZ F2 HARBI1 MDK ZNF408 	"F2 Dysprothrombinemia; F2 Hypoprothrombinemia; F2 Pregnancy loss, recurrent, susceptibility to, 2; F2 Stroke, ischemic, susceptibility to; F2 Thrombophilia due to thrombin defect; MDK Mesomelic dysplasia, Kantaputra type "	SCZ pmid=21747397; Bone mineral density p=5E-18 pmid=22504420; Bone mineral density (hip) p=4E-9 pmid=19801982; HDL cholesterol p=3E-18 pmid=20686565 	Ambra1 nervous; Arhgap1 nervous; Chrm4 behavioral neurological nervous; F2 nervous; Mdk behavioral neurological nervous 26	1.30E-11	chr3:180588843-181205585 	N 	CCDC39 DNAJC19 FXR1 	"CCDC39 Ciliary dyskinesia, primary, 14; DNAJC19 3- methylglutaconic aciduria, type V "		Fxr1 behavioral neurological 27	1.46E-11	chr20:37361494-37485994 	N 	ACTR5 PPP1R16B SLC32A1 			Slc32a1 behavioral neurological nervous 28	1.47E-11	chr2:57943593-58502192 	Y 	FANCL VRK2 	"FANCL Fanconi anemia, complementation group L "	SCZ pmid= 21791550 	29	1.62E-11	chr15:84661161-85153461 	N 	ADAMTSL3 GOLGA6L4 ZSCAN2 			30	1.97E-11	chr18:53453389-53804154 	N 	TCF4 * 			31	2.06E-11	chr2:198148577-198835577 	N 	ANKRD44 BOLL COQ10B HSPD1 HSPE1 MARS2 PLCL1 RFTN2 SF3B1 	"HSPD1 Leukodystrophy, hypomyelinating, 4; HSPD1 Spastic paraplegia 13, autosomal dominant; SF3B1 Myelodysplastic syndrome, somatic "	Intracranial aneurysm p=4E-8 pmid=18997786 	Plcl1 behavioral neurological nervous 32	2.07E-11	chr22:41408556-41675156 	N 	CHADL EP300 L3MBTL2 RANGAP1 	"EP300 Colorectal cancer, somatic; EP300 Rubinstein-Taybi syndrome 2 "	Crohn's disease p=3E-8 pmid=22936669 	Ep300 nervous 33	2.61E-11	chr8:111460061-111630761 	N 	KCNV1 * 			34	2.69E-11	chr3:2532786-2561686 	N 	CNTN4 			Cntn4 nervous 35	2.75E-11	chr11:113317794-113423994 	N 	DRD2 	"DRD2 Dystonia, myoclonic "		Drd2 behavioral neurological nervous 36	3.87E-11	chr11:133808069-133852969 	N 	IGSF9B 			37	4.26E-11	chr3:52541105-52903405 	Y 	GLT8D1 GNL3 ITIH1 ITIH3 ITIH4 MUSTN1 NEK4 NISCH NT5DC2 PBRM1 SMIM4 SPCS1 STAB1 TMEM110 TMEM110-MUSTN1 	"ITIH4 Hypercholesterolemia, susceptibility to "	SCZ pmid=22614287; Adiponectin levels p=1E-13 pmid=22479202; ASD-ADHD-BIP-MDD-SCZ p=3E-12 pmid=23453885; Immune response to smallpox (secreted IL-2) p=2E-9 pmid=22610502; Major mood disorders p=2E-9 pmid=20081856; Osteoarthritis p=5E-9 pmid=22763110 	38	4.55E-11	chr16:29924377-30144877 	N 	ALDOA ASPHD1 C16orf92 DOC2A FAM57B GDPD3 HIRIP3 INO80E KCTD13 MAPK3 PPP4C SEZ6L2 TAOK2 TBX6 TMEM219 YPEL3 	ALDOA Glycogen storage disease XII 	Pubertal anthropometrics p=9E-11 pmid=23449627 	Doc2a behavioral neurological nervous; Mapk3 behavioral neurological nervous; Sez6l2 behavioral neurological nervous; Tbx6 nervous 39	4.73E-11	chr22:39975317-40016817 	N 	CACNA1I 			40	7.26E-11	chr3:135807405-136615405 	N 	MSL2 NCK1 PCCB PPP2R3A SLC35G2 STAG1 	PCCB Propionicacidemia 	Fibrinogen p=6E-10 pmid=20031576; Height p=4E-9 pmid=20881960; Triglycerides p=3E-8 pmid=20686565 	Nck1 behavioral neurological nervous 41	1.06E-10	chr5:151941104-152797656 	Y 	GRIA1 * 		SCZ pmid = 23974872 	42	1.98E-10	chrX:68377126-68379036 	N 	PJA1 			43	2.86E-10	chr17:2095899-2220799 	N 	SGSM2 SMG6 SRR TSR1 		Aortic root size p=2E-11 pmid=19584346; Coronary heart disease p=9E-10 pmid=21378990; Esophageal cancer (squamous cell) p=2E-11 pmid=22960999; Type 2 diabetes p=3E-9 pmid=20174558 	Srr behavioral neurological nervous 44	3.33E-10	chr7:86403226-86459326 	N 	GRM3 			Grm3 behavioral neurological 45	3.38E-10	chr15:61831663-61909663 	N 	VPS14C * 			46	3.39E-10	chr1:44029384-44128084 	N 	KDM4A PTPRF 			Ptprf behavioral neurological nervous 47	3.63E-10	chr19:19374022-19658022 	Y 	CILP2 GATAD2A HAPLN4 MAU2 NCAN NDUFA13 PBX4 SUGP1 TM6SF2 TSSK6 	"NDUFA13 Thyroid carcinoma, Hurthle cell "	"SCZ pmid = 23974872; Cholesterol, total p=3E-38 pmid=20686565; LDL cholesterol p=7E-22 pmid=20686565; Triglycerides p=2E- 29 pmid=20686565 "	Gatad2a nervous; Ncan nervous 48	4.49E-10	chr1:149998890-150242490 	N 	ANP32E APH1A C1orf51 C1orf54 CA14 OTUD7B PLEKHO1 VPS45 			Anp32e behavioral neurological; Aph1a nervous 49	8.15E-10	chr6:84279922-84407274 	N 	SNAP91 			50	8.70E-10	chr1:2372401-2402501 	N 	PLCH2 		Non-obstructive azoospermia p=6E- 12 pmid=22197933 	51	1.01E-09	chr16:13728459-13761359 	N 	ERCC4 * 			52	1.13E-09	chr7:104598064-105063064 	N 	MLL5 PUS7 SRPK2 			53	1.17E-09	chr1:8411184-8638984 	N 	RERE SLC45A1 	"RERE Leukemia, acute myeloid, with eosinophilia "	Vitiligo p=7E-15 pmid=20410501 	Rere nervous 54	1.40E-09	chr12:110723245-110723245 	N 	ATP2A2 	ATP2A2 Acrokeratosis verruciformis; ATP2A2 Darier disease 		Atp2a2 behavioral neurological 55	1.47E-09	chr4:170357552-170646052 	N 	C4orf27 CLCN3 NEK1 	"NEK1 Short rib-polydactyly syndrome, type IIA "		Clcn3 behavioral neurological nervous; Nek1 nervous 56	1.64E-09	chr6:96459651-96459651 	N 	FUT9 			57	1.71E-09	chr22:42315744-42689414 	N 	CENPM CYP2D6 FAM109B NAGA NDUFA6 SEPT3 SHISA8 SMDT1 SREBF2 TCF20 TNFRSF13C WBP2NL 	"CYP2D6 Codeine sensitivity; CYP2D6 Debrisoquine sensitivity; NAGA Kanzaki disease; NAGA Schindler disease, type I; NAGA Schindler disease, type III; TNFRSF13C Immunodeficiency, common variable, 4 "		Sept3 nervous 58	1.81E-09	chr2:146416922-146441832 	N 				59	2.24E-09	chr11:57386294-57682294 	N 	BTBD18 C11orf31 CLP1N CTNND1 MED19 SERPING1 TMX2 YPEL4 ZDHHC5 	"SERPING1 Angioedema, hereditary, types I and II; SERPING1 Complement component 4, partial deficiency of "		Ctnnd1 nervous 60	2.55E-09	chr11:24367320-24412990 	N	LUZP2 * 			61	2.86E-09	chr1:30412551-30437271 	N 				62	3.28E-09	chr7:137039644-137085244 	N	DGKI PTN 			Ptn behavioral neurological nervous 63	3.61E-09	chr9:84630941-84813641 	N	TLE1 			64	3.73E-09	chr1:243503719-244002945 	Y	AKT3 SDCCAG8 	AKT3 Megalencephaly- polymicrogyria-polydactyly- hydrocephalus syndrome; SDCCAG8 Senior-Loken syndrome 7 	SCZ pmid=22614287 	Akt3 behavioral neurological nervous 65	4.18E-09	chr15:40566759-40602237 	N	ANKRD63 PAK6 PLCB2 	PLCB2 Platelet PLC beta-2 deficiency 		Pak6 behavioral neurological nervous 66	4.49E-09	chr19:30981643-31039023 	N	ZNF536 		Myopia (pathological) p=3E-12 pmid=23049088 	67	4.61E-09	chr5:88581331-88854331 	N	MEF2C * 			68	4.64E-09	chr3:17221366-17888266 	N	TBC1D5 			69	4.67E-09	chr5:137598121-137948092 	N	CDC25C CTNNA1 EGR1 ETF1 N FAM53C GFRA3 HSPA9 KDM3B REEP2 			Ctnna1 nervous; Egr1 behavioral neurological nervous; Gfra3 nervous 70	4.80E-09	chr14:99707919-99719219 	N	BCL11B 			Bcl11b behavioral neurological 71	4.86E-09	chr14:72417326-72450526 	N	AC005477.1 RGS6 			72	5.05E-09	chr5:45291475-45393775 	N	HCN1 			Hcn1 behavioral neurological nervous 73	5.97E-09	chr8:60475469-60954469 	N	CA8 * 			74	7.39E-09	chr2:72357335-72368185 	N	CYP26B1 	CYP26B1 Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies 		75	7.54E-09	chr11:123394636-123395986 	N	GRAMD1B 			76	8.33E-09	chr2:200161422-200309252 	N	SATB2 	SATB2 Cleft palate and mental retardation 		77	8.41E-09	chr2:193848340-194028340 	Y	PCGEM1 * 		SCZ pmid = 21926974 	78	9.47E-09	chr4:176851001-176875801 	N	GPM6A 			79	1.06E-08	chr8:4177794-4192544 	Y	CSMD1 		SCZ=pmid 21926974; ASD-ADHD- BIP-MDD-SCZ p=4E-8 pmid=23453885; SCZ p=2E-8 pmid=21926974 	80	1.12E-08	chr2:225334096-225467796 	N	CUL3 	"CUL3 Pseudohypoaldosteronism, type IIE "		81	1.22E-08	chr8:89340626-89753626 	Y	MMP16 		SCZ pmid = 21926974 	82	1.28E-08	chr16:9875519-9970219 	N	GRIN2A 	GRIN2A Epilepsy with neurodevelopmental defects 		Grin2a behavioral neurological nervous 83	1.41E-08	chr14:30189985-30190316 	N	PRKD1 			84	1.43E-08	chr3:63792650-64004050 	N	ATXN7 C3orf49 PSMD6 THOC7 	ATXN7 Spinocerebellar ataxia 7 		Atxn7 behavioral neurological nervous 85	1.51E-08	chr16:67709340-68311340 	N	ACD C16orf86 CENPT CTRL DDX28 DPEP2 DPEP3 DUS2L EDC4 ENKD1 ESRP2 GFOD2 LCAT NFATC3 NRN1L NUTF2 PARD6A PLA2G15 PSKH1 PSMB10 RANBP10 SLC12A4 SLC7A6 SLC7A6OS THAP11 TSNAXIP1 	LCAT Fish-eye disease; LCAT Norum disease 	HDL cholesterol p=8E-33 pmid=20686565; Metabolic syndrome p=2E-10 pmid=22399527 	Nfatc3 behavioral neurological nervous 86	1.59E-08	chr2:149390778-149520178 	N	EPC2 			87	1.77E-08	chr17:17722402-18030202 	N 	ATPAF2 DRG2 GID4 LRRC48 MYO15A RAI1 SREBF1 TOM1L2 	"ATPAF2 Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1; MYO15A Deafness, autosomal recessive 3; RAI1 Smith-Magenis syndrome "		Myo15 behavioral neurological nervous; Rai1 behavioral neurological nervous; Tom1l2 behavioral neurological nervous 88	1.79E-08	chr15:70573672-70628872 	N 	TLE3 * 			89	1.87E-08	chr16:58669293-58682833 	N 	CNOT1 SLC38A7 			90	2.10E-08	chr8:27412627-27453627 	N 	CLU EPHX2 	"EPHX2 Hypercholesterolemia, familial, due to LDLR defect, modifier of; GULOP Scurvy "		Clu nervous; Gulo behavioral neurological nervous 91	2.21E-08	chrX:5916533-6032733 	N 	NLGN4X 	"NLGN4X Asperger syndrome susceptibility, X-linked 2; NLGN4X Autism susceptibility, X-linked 2; NLGN4X Mental retardation, X- linked "		92	2.69E-08	chr6:73132701-73171901 	N 	RIMS1 	RIMS1 Cone-rod dystrophy 7 		Rims1 behavioral neurological nervous 93	2.85E-08	chr7:24619494-24832094 	N 	DFNA5 MPP6 OSBPL3 	"DFNA5 Deafness, autosomal dominant 5 "		Dfna5 nervous 94	3.05E-08	chr5:109030036-109209066 	N 	MAN2A1 			95	3.06E-08	chr4:23366403-23443403 	N 	MIR548AJ2 * 			96	3.15E-08	chr5:153671057-153688217 	N 	GALNT10 			97	3.70E-08	chr11:109285471-109610071 	N 	C11orf87 			98	3.71E-08	chr7:110034393-110106693 	N 	IMMP2L * 			99	3.91E-08	chr12:29905265-29940365 	N 	TMTC1 			100	4.42E-08	chr7:131539263-131567263 	N 	PODXL * 			101	4.45E-08	chr1:177247821-177300821 	N 	FAM5B 			102	4.47E-08	chr1:207912183-208024083 	N 	C1orf132 CD46 CR1L 	"CD46 Hemolytic uremic syndrome, atypical, susceptibility to, 2 "		103	4.56E-08	chr20:48114136-48131649 	N 	KCNB1 PTGIS 	"PTGIS Hypertension, essential "		104	4.59E-08	chr12:92243186-92258286 	N 	C12orf79 * 			105	4.62E-08	chr2:162798555-162910255 	N 	DPP4 SLC4A10 			Slc4a10 behavioral neurological nervous 106	4.69E-08	chr19:50067499-50135399 	N 	NOSIP PRR12 PRRG2 RCN3 RRAS SCAF1 			107	4.84E-08	chr12:103559855-103616655 	N 	C12orf42 			108	4.85E-08	chr5:140023664-140222664 	N 	AC005609.1 CD14 DND1 HARS HARS2 IK NDUFA2 PCDHA1 PCDHA10 PCDHA2 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 TMCO6 WDR55 ZMAT2 	HARS Usher syndrome type 3B; HARS2 Perrault syndrome 2; NDUFA2 Leigh syndrome due to mitochondrial complex I deficiency 		